olivLaw · US equity research
LanzaTech Global, Inc. LNZA
Industrial Organic Chemicals · SIC 2860 · Vertical: Industrial Organic Chemicals (SIC 2860)
LanzaTech is a technology company that turns industrial waste gases into ethanol and other chemicals through gas fermentation, using a licensing and co-development model. The company remains loss-making, but in 2026 it cut costs and reinstated financial guidance, while its latest annual report flagged substantial doubt about going concern. Annual revenue for fiscal 2025 was 55.845 million USD, and the net loss was 49.0 million USD.
At the close of 04 Nov 2026, LanzaTech Global, Inc. (LNZA) stock was 5.29 USD (+4.13% on the day), with market capitalisation 69.2 m USD, P/E 0.4 on diluted EPS of 14.99 USD over the last 12 months, beta 2.50, 52-week range 4.45–41.42 USD. Latest reported quarter (Q2 2026): revenue of 9.0 m USD (−0.8% YoY), net income of 184.3 m USD, diluted EPS 15.81 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 49.7
- neutral
- Bollinger (20, 2)
- 4.18 – 6.12
- in the upper half of the band · %B 0.57 · band width 37.7%
- SMA 50 / 200
- 5.69 / 10.58
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.16 / -0.22
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −10.5% | −1.1% | −9.4 pp | — |
| 3 months | −17.3% | −0.5% | −16.9 pp | — |
| 6 months | −76.1% | +4.4% | −80.5 pp | — |
| Year to date | −61.6% | +12.3% | −73.9 pp | — |
| 1 year | −72.6% | +13.5% | −86.1 pp | −1.7% |
| 3 years | −98.7% | +76.4% | −175.1 pp | −26.4% |
| 5 years | −99.5% | +63.7% | −163.1 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.9 m | 12.0 m | 9.5 m | 9.1 m | 9.3 m | 28.0 m | 12.0 m | 9.0 m |
| Research & development | 22.0 m | 16.5 m | 16.5 m | 14.9 m | 10.3 m | 11.5 m | 4.0 m | 2.0 m |
| SG&A | 11.5 m | 15.7 m | 15.7 m | 19.1 m | 6.7 m | 5.5 m | 8.6 m | 8.8 m |
| Operating income | -33.0 m | -27.0 m | -31.1 m | -32.2 m | -15.7 m | -205.0 k | -9.8 m | -9.9 m |
| Pre-tax income | -51.9 m | -20.7 m | -12.7 m | — | — | — | — | — |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -57.4 m | -27.0 m | -19.2 m | -32.5 m | 2.9 m | -84.0 k | -14.7 m | 184.3 m |
| Diluted EPS | -29.04 | -13.65 ≈ | -9.79 | -14.90 | 0.99 | -0.04 ≈ | -1.77 | 15.81 |
| Operating cash flow | -26.4 m ≈ | -19.7 m | -21.1 m | -21.7 m ≈ | -15.9 m ≈ | -6.2 m | -9.3 m | -1.4 m ≈ |
| Capex | 289.0 k ≈ | 1.8 m | 713.0 k | 166.0 k ≈ | 168.0 k ≈ | 211.0 k | 55.0 k | 676.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 0 percentile of its own 1-quarter history (min 0.5, median 0.5, max 0.5; quarters with earnings only).
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 37.3 m | 62.6 m | 49.6 m | 55.8 m |
| Revenue YoY | unavailable | +67.7% | −20.8% | +12.6% |
| Net income | -76.4 m | -134.1 m | -137.7 m | -49.0 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | -12.37 | -0.79 | -69.71 | -22.27 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable |
| net % | -204.5% | -214.1% | -277.7% | -87.7% |
| Free cash flow | -95.4 m | -105.8 m | -94.4 m | -66.1 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 13.2 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- -3.9 m USD
- Total assets
- 100.2 m USD
- Debt / equity
- unavailable
- Current ratio
- 1.43x
- ROE
- unavailable
- ROA
- -35.6%
- FCF margin
- -118.4%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Revenue | 37.3 m | 62.6 m | 49.6 m | 55.8 m | SEC (XBRL)· 31 Mar 2026verified |
| Research & development | 53.2 m | 68.1 m | 77.0 m | 53.2 m | SEC (XBRL)· 31 Mar 2026verified |
| SG&A | 26.8 m | 50.4 m | 50.0 m | 47.0 m | SEC (XBRL)· 31 Mar 2026verified |
| Operating income | -75.6 m | -106.4 m | -108.9 m | -79.2 m | SEC (XBRL)· 31 Mar 2026verified |
| Pre-tax income | -1.0 m | -131.2 m | -123.5 m | — | SEC (XBRL)· 15 Apr 2025verified |
| Income tax | 0 | 0 | 0 | 0 | SEC (XBRL)· 31 Mar 2026verified |
| Net income | -76.4 m | -134.1 m | -137.7 m | -49.0 m | SEC (XBRL)· 31 Mar 2026verified |
| Diluted EPS | -12.37 | -0.79 | -69.71 | -22.27 | SEC (XBRL)· 31 Mar 2026verified |
| Weighted average diluted shares | 9.3 m | 176.0 m | 2.0 m | 2.2 m | SEC (XBRL)· 31 Mar 2026verified |
Balance sheet · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Cash | 83.0 m | 75.6 m | 43.5 m | 13.2 m | SEC (XBRL)· 31 Mar 2026verified |
| Inventories | 1.1 m | 1.8 m | 2.2 m | 684.0 k | SEC (XBRL)· 31 Mar 2026verified |
| Current assets | 123.9 m | 172.7 m | 99.3 m | 39.7 m | SEC (XBRL)· 31 Mar 2026verified |
| Property, plant & equipment, net | 19.7 m | 22.8 m | 22.3 m | 17.1 m | SEC (XBRL)· 31 Mar 2026verified |
| Total assets | 176.9 m | 241.6 m | 174.7 m | 100.2 m | SEC (XBRL)· 31 Mar 2026verified |
| Accounts payable | 7.5 m | 4.1 m | 5.3 m | 10.9 m | SEC (XBRL)· 31 Mar 2026verified |
| Long-term debt | 50.0 m | 25.2 m | — | — | SEC (XBRL)· 29 Feb 2024verified |
| Current liabilities | 56.0 m | 27.8 m | 30.4 m | 27.7 m | SEC (XBRL)· 31 Mar 2026verified |
| Total liabilities | 124.9 m | 127.2 m | 161.2 m | 90.9 m | SEC (XBRL)· 31 Mar 2026verified |
| Equity | -428.7 m † | 114.5 m † | 13.4 m † | -3.9 m † | SEC (XBRL)· 31 Mar 2026verified |
| Shares outstanding at year end | — | 196.6 m | — | — | SEC (XBRL)· 29 Feb 2024verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Operating cash flow | -84.7 m | -97.3 m | -89.1 m | -64.9 m | SEC (XBRL)· 31 Mar 2026verified |
| Capex | 10.7 m | 8.6 m | 5.3 m | 1.3 m | SEC (XBRL)· 31 Mar 2026verified |
| Free cash flow | -95.4 m ≈ | -105.8 m ≈ | -94.4 m ≈ | -66.1 m ≈ | SEC (XBRL)· 31 Mar 2026derived |
| Investing cash flow | -10.7 m | -57.9 m | 28.4 m | 11.2 m | SEC (XBRL)· 31 Mar 2026verified |
| Financing cash flow | 50.5 m | 148.2 m | 30.2 m | 25.6 m | SEC (XBRL)· 31 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- score weight coverage: 43.8% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 69.2 m USD
Key indicators
Coverage and freshness
Score by group
44% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 143.06 – 227.35 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E143.06 – 227.35 (Mid 193.06)7 companies used · median multiple 12.9x · quartiles 9.5x – 15.2xALTO, GPRE, LYB, NEU, REX, SXT, WLKP
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 43.8% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 295.7% | 100 (vs peers) | 14% |
| FCF conversion · Quality | -19.6% | 0 (on a fixed band) | 14% |
| Revenue CAGR 3Y · Growth | 14.4% | 100 (on a fixed band) | 19% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 2.5x | 100 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | 0.4x | 100 (vs peers) | 24% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -48.8% | 0 (on a fixed band) | 19% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth· partial100/100 · 1/2 factors with a value
- Quality50/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation56/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
LanzaTech Global, Inc. (LNZA). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 55.8 m USD in 2025; YoY growth 12.6%; net margin 295.7%; ROE 146.4%.
The estimated value range is 143.06–227.35 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 193.06 USD, the price of 5.29 USD leaves a potential of 3,549.6% (value / price − 1) and a margin of safety of 97.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 43.8% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 295.7%
- Revenue CAGR 3Y: 14.4%
- Current ratio: 2.5x
- P/E (TTM): 0.4x
- The price is below the estimated value range
What contradicts it
- FCF conversion: -19.6%
- FCF yield: -48.8%
Not assessed (insufficient data or a ratio without meaning): ROIC, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Industrial Organic Chemicals (SIC 2860) · same industry (4-digit SIC) · compared with 20 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| IFFInternational Flavors & Fragrances Inc | 22.0 bn | 122.1 | 1.3% | 1.6% | −5.2% | +26% / +16% |
| LYBLyondellbasell Industries N.V. | 20.4 bn | 15.6 | 11.9% | 4.1% | −9.7% | +29% / −34% |
| WLKWestlake Corporation | 8.7 bn | — | -4.9% | -3.9% | −8.0% | +2% / −47% |
| NEUNewmarket Corporation | 6.7 bn | 14.7 | 25.3% | 16.5% | −2.2% | −5% / +37% |
| SXTSensient Technologies Corp | 5.4 bn | 31.7 | 13.7% | 9.7% | +3.5% | +29% / +117% |
| MEOHMethanex Corporation | 5.0 bn | 70.1 | 6.4% | 4.0% | −3.5% | +83% / +53% |
| REXRex American Resources Corporation | 1.3 bn | 10.5 | 22.5% | 20.9% | +1.2% | +20% / +62% |
| GPREGreen Plains Inc. | 957.5 m | 8.6 | 15.4% | 6.8% | −14.9% | +32% / −45% |
| WLKPWestlake Chemical Partners LP | 761.8 m | 12.9 | — | 4.8% | +2.7% | +14% / −5% |
| GEVOGevo, Inc. | 316.5 m | — | -57.0% | -119.9% | +849.3% | −40% / +13% |
| ALTOAlto Ingredients, Inc. | 271.5 m | 5.3 | 22.2% | 5.5% | −4.9% | +37% / +43% |
| FFFuturefuel Corp. | 246.5 m | — | -18.3% | -19.9% | −60.7% | +70% / −5% |
| CDXSCodexis, Inc. | 118.3 m | — | -69.4% | -39.6% | +18.6% | −38% / −54% |
| LODEComstock Inc. | 113.3 m | — | -38.2% | -3,680.5% | −48.5% | −58% / −68% |
| AMTXAemetis, Inc | 90.2 m | — | — | -27.4% | −26.2% | −28% / −72% |
| TANHTantech Holdings Ltd | 90.1 m | — | -25.7% | -80.9% | −10.7% | −76% / −100% |
| LNZALanzaTech Global, Inc. | 69.2 m | 0.4 | 146.4% | 295.7% | +12.6% | −73% / −99% |
| SAFXXcf Global, Inc. | 41.0 m | — | -246.1% | — | unavailable | −87% / unavailable |
| TOMZTomi Environmental Solutions, Inc. | 18.2 m | — | -168.8% | -49.8% | −27.2% | −6% / −26% |
| CNEYCn Energy Group. Inc. | 2.5 m | — | -11.2% | -31.3% | −30.2% | −65% / −99% |
| BAKBraskem SA | — | — | — | -14.6% | +9.7% | −61% / −86% |
1- and 3-year price returns: for LNZA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 3.02 Total return -43% · Per year -43% | 5.31 Total return 0% · Per year 0% | 7.97 Total return 51% · Per year 51% |
| 3 years | 3.54 Total return -33% · Per year -13% | 6.95 Total return 31% · Per year 10% | 11.36 Total return 115% · Per year 29% |
| 5 years | 4.15 Total return -22% · Per year -5% | 9.09 Total return 72% · Per year 11% | 16.18 Total return 206% · Per year 25% |
- Exit P/E± 1.74
- Net margin± 1.22
- Annual revenue growth± 0.91
- Annual dilution± 0.10
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
LanzaTech is a technology company that turns industrial waste gases into ethanol and other chemicals through gas fermentation, using a licensing and co-development model. The company remains loss-making, but in 2026 it cut costs and reinstated financial guidance, while its latest annual report flagged substantial doubt about going concern 13. Annual revenue for fiscal 2025 was 55.845 million USD 1, and the net loss was 49.0 million USD 1.
SWOT
Strengths
- The gas fermentation platform is validated through commercial plants and years of pilot operation, giving a solid technical base 1.
- The intellectual property portfolio is broad, and licensed rights reinforce the company's position 1.
- Costs were cut across 2025 and 2026, and operating expenses in the second quarter fell sharply year on year 3.
Weaknesses
- The company has not achieved operating profitability and reports substantial doubt about its ability to continue as a going concern 1.
- Revenue is modest relative to funding needs, and cash at the end of 2025 was low 1.
- Net income in 2026 is driven by non-cash accounting gains that do not reflect operating cash receipts 23.
Opportunities
Risks
- Going concern doubthigh
Management concluded there is substantial doubt about the company's ability to continue operating without additional capital 1.
- Dilution from share issuancehigh
Additional funding could involve share or convertible issuances that reduce existing shareholders' stakes 1.
- Delays in federal fundingmedium
Delays in government funds could postpone projects and related revenue, especially in earlier cohorts 13.
- No operating profitabilitymedium
The company has not reached operating profit and cannot guarantee when or whether it will become profitable 1.
- Dependence on partnerslow
Royalty revenue depends on partners' product prices, and losing partners could affect scaling 1.
Investment thesis
What would need to be true (bull case)
- If first-cohort projects reach financing, recurring revenue could grow and reduce reliance on external funding 13.
- ISCC EU certification could open mandated markets, giving CarbonSmart ethanol access to regulated demand 3.
- Lower operating costs could move the company closer to financial balance if revenue rises in line with guidance 3.
What would break the thesis
- Going concern doubts could discourage financiers and partners, delaying projects 1.
- Non-cash accounting gains on the SGLT and LanzaJet stakes do not reflect operating cash receipts and can be volatile 23.
- If government funding is delayed or European mandates do not materialise, revenue could stay below expectations 13.
What to watch
- Delivery against 2026 revenue and adjusted EBITDA guidanceQ3 2026
- Final investment decision on the Belgian SAF project2027
- ISCC EU certification of recycled carbon fuels in China2027
- New equity or financing that could ease going-concern doubtsnext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
LanzaTech, headquartered in Skokie, Illinois, develops carbon management technologies that convert waste gases into fuels, chemicals and industrial inputs 1. Its gas fermentation platform uses specialised microbes to turn gases from steel mills, refineries or gasified waste into ethanol and derivatives such as SAF, ethylene or PET 1. The company earns revenue through licences, supply sales, engineering services and co-development projects where it holds a minority stake 1.
The business model combines royalties, microbe supply and software with co-owned projects, and the company is gradually expanding its stake in the biorefining value chain 12. In 2025 it moved from one-off projects to a cohort model that groups projects by maturity and financing readiness 1. Recurring revenue rose in 2025 to 20.954 million USD 1.
The platform has been validated commercially through six plants, the first launched in China in 2018, with further facilities in India and Belgium 1. The company also holds a stake in LanzaJet, an SAF firm whose holding was diluted in February 2026 1. Its interest in the SGLT joint venture was remeasured after the Hong Kong listing, producing a non-cash accounting gain in the second quarter of 2026 3.
Segments
Licensing and royalties
Customers build, own and operate plants using LanzaTech technology, and the company collects a royalty on their revenue 2. Recurring revenue, including royalties and microbe supply, reached 20.954 million USD in 2025 1.
Market context
The target market is carbon capture and utilisation technology, where industrial operators look to unlock value from existing assets and secure supply chains 1. The company describes energy security, industrial resilience and supportive tax frameworks in key markets as favourable for deployment 1.
The market for sustainable aviation fuel and recycled fuels in Europe depends on the regulatory framework, and the company could benefit if mandates expand 3. The company says waste carbon feedstocks are abundant and low-cost, but realising that potential depends on project financing 1.
Trends
- Public policy on energy and industrytailwind
A federal emphasis on energy leadership and industrial competitiveness could create demand for CCU technologies that use domestic resources 1.
- Sustainable fuel mandates in Europetailwind
ISCC EU certification could open mandated markets for CarbonSmart ethanol if carbon tracing standards are accepted 3.
- Delays in government fundingheadwind
Projects tied to Department of Energy programmes could be postponed if federal funding is delayed, pushing revenue later 1.
- Access to capitalmixed
Reliance on external funding and dilution from new share issuance could limit the pace of development, although the company raised capital in 2026 12.
Competitive position
The company says it does not view any single firm as a direct competitor across its whole business, but some companies overlap in feedstocks, products, synthetic biology or commercial scale 1. Competitors could have greater financial, research or marketing resources 1.
Competitive risk rises if more investors fund carbon circular economy technologies, and rivals could launch products without prior notice 1. The company argues that no other firm currently delivers all of its capabilities in an integrated way 1.
- Firms overlapping in feedstocks and products
Companies cited generically in the annual report as overlapping in feedstocks and products, not named in the sources provided.
- Synthetic biology firms
Synthetic biology competitors mentioned in the report as having experience in similar process design.
- Thermocatalytic process providers
Traditional catalytic technologies are described by the company as an alternative to gas fermentation.
- SAF and waste-based fuel producers
Companies producing sustainable aviation fuel from similar feedstocks, referred to generically in the SAF market context.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report20 Oct 2026Material agreement · Creation of a direct financial obligation · Item 3.02 · Other events
- Quarterly report14 Aug 2026
- Current report14 Aug 2026Results of operations · Financial statements and exhibits
- Current report24 Jun 2026Shareholder vote · Financial statements and exhibits
- Current report04 Jun 2026Other events · Financial statements and exhibits
- Current report18 May 2026Material agreement · Financial statements and exhibits
- Quarterly report14 May 2026
- Current report14 May 2026Results of operations · Financial statements and exhibits
- Current report04 May 2026Regulation FD disclosure · Financial statements and exhibits
- Proxy statement29 Apr 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / LanzaTech Global, Inc. · 31 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / LanzaTech Global, Inc. · 14 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / LanzaTech Global, Inc. · 14 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.